An HRB Probiotic Strain for Weight Management
Specializing in weight management, B. breve B-3 is an exceptional Human-Residential Bifidobacteria (HRB) probiotic strain that places strong emphasis on its interaction with gut microbiota to promote and maintain healthy metabolic processes. Notably, B. breve B-3 was originally sourced from the gut of an infant.*
B. breve B-3 plays a crucial role in helping individuals maintain a healthy weight and body fat percentage. Furthermore, its exceptional stability allows it to thrive at room temperature, making it a convenient and reliable choice for daily supplementation.*
Resources
Explore our range of downloadable resources and gain insights into the crucial role of the gut microbiota, the thriving gut health market, and infographics and clinical studies backing B. breve B-3. Learn more about partnering with Morinaga as your probiotics supplier.
B. breve B-3 is a valued functional ingredient in a diverse range of products. Depending on what you need from a probiotics manufacturer, we can accommodate a variety of product requests targeted at different consumer segments and health areas.*
Legislation can be varied by country when it comes to specific dosage and potential health claims of each strain.
Our regulatory team can help and advise you as to the appropriate individual markets permit. Morinaga’s global regulatory experts are in all major regions. We are committed to delivering expert advice and practical solutions to optimize your company’s success.
The information on this website is intended exclusively for business-to-business purposes and is not intended for end-consumer utilization. It is predicated upon our rigorous research and development endeavors and, to the best of our knowledge, is deemed reliable. Morinaga disclaims any liability arising from the utilization of its products, as the terms of employment are beyond our purview. The business-oriented information furnished herein should not be construed as a substitute for professional counsel. Prior to implementation, manufacturers and marketers are advised to ascertain compliance with local regulatory prerequisites, given that divergent claims may be permissible contingent upon the prevailing regulations in individual countries. This presentation is purely informative in a scientific context and does not constitute claims or marketing notifications within the jurisdiction of the United States.
Explore the Morinaga Probiotics Center to delve into key highlights showcasing the clinical efficacy of B. breve B-3.
Be Inspired to Innovate with HRB Probiotics
Elevate your product quality with science-backed, functional ingredients.